In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. 2005
alf: cd25 expansion treg

Targeting Acute Allograft Rejection by Immunotherapy With Ex Vivo-Expanded Natural CD4+CD25+ Regulatory T Cells. 2006
alf: cd25 expansion treg

Ex vivo activated OVA specific and non-specific CD4(+)CD25(+) regulatory T cells exhibit comparable suppression to OVA mediated T cell responses. 2006
alf: cd25 ova specificity treg

Competition controls the rate of transition between the peripheral pools of CD4+CD25- and CD4+CD25+ T cells. 2006
alf: cd25 competition

Signaling through 4-1bb receptor reversibly inhibits the suppressive function of cd4+cd25+foxp3+ T regulatory cells. 2006
alf: 4-1bb cd25

Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. 2006
alf: cancer cd25

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T cell lines upon in vitro expansion. 2006
alf: cd25 treg

Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. 2006
alf: cd25 periphery treg

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. 2006
alf: cd25 treatment

Comment on "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells". 2006
alf: cd25 pc61

older →